Stock screener

QTTB

Conviction 47HealthcareScan · Thu, Sep 24, 2026

Q32 Bio Inc. (QTTB) closed at $9.20 (-3.77%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 22, RS Rating 99, -57.0% from its 52-week high, +167.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

QTTB$9.20-3.77%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
3
Vol MA14 801.49K
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Q32 Bio Inc.PHARMACEUTICAL PREPARATIONSwww.q32bio.com ↗
Price9.20
Change-3.77%
Gap-0.89%
Rel volume2.67×
Avg volume669.3K
Avg $ vol7.53M
SMA 2011.89
SMA 5014.10
SMA 2008.56
Price vs 50-34.77%
Price vs 200+7.48%
MA stackmixed
50/200 cross—
Supertrenddown · 11.43
RSI (14)22
MACD hist-0.17
MACD cross—
Stoch %K / %D4 / 4
ADX (14)39
+DI / −DI11 / 39
RSI divergence—
MACD divergence—
ATR %8.48%
ADR %6.04%
52w high21.38
52w low1.87
From 52w high-56.97%
Above 52w low+391.98%
New 52w highNo
SqueezeOff
Bollinger width63.38%
%B0.14
Donchian pos1.93%
Donchian high16.30
Donchian low9.06
AVWAP (52w high)14.71
vs AVWAP high-37.48%
AVWAP (52w low)8.08
vs AVWAP low+13.85%
OBV trendDown
Chaikin MF (20)-0.29
Today vs 20d2.67×
Avg vol (14d)801.49K
Avg vol (20d)669.3K
Avg $ vol (20d)7.53M
Market cap273.88M
RS Rating99 / 99
RS 3m (vs SPY)-27.50%
RS 6m (vs SPY)+10.08%
RS line new highNo
Trend template4/8
Technical rank50.8
1 week-15.29%
1 month-43.63%
3 months-23.01%
6 months+26.90%
1 year+408.29%
YTD+167.44%
P/E9.18
P/B2.59
P/S236.92
P/FCF-8.16
EPS2.42
Div yield—
ROE28.16%
ROA25.74%
Debt/Eq—
Current20.30
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-63.97%
EPS growth162.47%
Price target41.00
Target upside345.65%
Analyst ratingBuy
Institutional75.58%
Ent. value167.61M
Revenue0
Net income-8.95M
Gross profit—
Free cash flow-33.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out16.96M
Employees22
ListedTue, Mar 26, 2024
Free float5.55M
Float %38.0%
Short interest3.56M
Days to cover9.5d
Short volume28.9%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.44 vs −$0.53
Last surprise+17.0% beat
Setup gradeC
Conviction47 / 100
Pattern quality—
Tech rank50.8 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance16.97
Support12.62
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QTTB

All disclosures →
No recent disclosed trades by Congress in QTTB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QTTB · open-market 7 buys · 3 sells

InsiderSideShares
Kalowski Lee
CFO and President · Common Stock · 2026-08-25
Sell3.97K
Morrison Jodie Pope
CEO · Common Stock · 2026-08-25
Sell9.85K
Violette Shelia M.
Chief Scientific Officer · Common Stock · 2026-08-25
Sell2.8K
OrbiMed Genesis GP LLC
Director · Common Stock · 2026-05-28
Buy625K
ORBIMED ADVISORS LLC
Director · Common Stock · 2026-05-28
Buy625K
OrbiMed Capital GP VII LLC
Director · Common Stock · 2026-05-28
Buy625K
OrbiMed Genesis GP LLC
Director · Common Stock · 2026-05-28
Buy1.25M
ORBIMED ADVISORS LLC
Director · Common Stock · 2026-05-28
Buy1.25M
Xu Diyong
Director · Common Stock · 2026-05-28
Buy1.25M
OrbiMed Capital GP VII LLC
Director · Common Stock · 2026-05-28
Buy1.25M

SEC filings

EDGAR filings in QTTB · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.